Coronavirus survivors who get vaccinated respond up to seven times better to it than those who haven’t had the virus, a study has found. Researchers found that antibody levels were three times higher in people who had the virus and then one dose of Pfizer‘s jab, compared to someone who had never been infected but … Read more
Regeneron’s coronavirus antibody cocktail is effective at treating mild to moderate cases of COVID-19, new late-stage trial results suggest. The treatment is a mixture of drugs casirivimab and imdevimab, and was developed by the New York City-based company in partnership with pharmaceutical firm Roche. Known as REGEN-COV, the cocktail imitates antibodies that the body generates … Read more
The closest thing to a COVID ‘cure’? Eli Lilly’s combination antibody drug cuts the risk of COVID-19 hospitalization and death by 87%, study finds The combination treatment, a mixture of two drugs, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body Half a group of 769 mild-to-moderate COVID-19 patients at … Read more
Antibody cocktail drugs that offered ‘great hope’ in treating Covid-19 are ineffective against worrying new variants of the virus, research suggests. Lab tests found the experimental treatments, known as monoclonal antibodies, failed to neutralise strains one or more of strains which emerged in Kent, South Africa and Brazil. The drugs are derived from cloning a … Read more
People previously infected with coronavirus may only need one dose of the vaccine, a new study suggests. Researchers found that participants who had contracted COVID-19 in the past and received one shot had antibody levels similar to – and even higher than – those who had never been infected and were given two doses. Additionally, … Read more
An experimental coronavirus drug which is now being trialled on the NHS has been found to cause a 100 per cent reduction in symptomatic infections and also reduce overall infection rates. Regeneron Pharmaceuticals Inc said on Tuesday that its two-antibody cocktail REGEN-COV prevented 100 per cent of the 186 people who got the drug after being … Read more
A new antibody treatment with the potential to give people instant immunity after being exposed to Covid-19 and prevent illness is being trialled by British scientists in the UK. The drug would offer immediate and long-term protection to patients when it would be too late to offer a vaccine, potentially saving thousands of lives. It … Read more
The majority of doses of coronavirus antibody drugs are going unused, a new report claims. According to CNBC, Operation Warp Speed ships out some 65,000 doses of the drugs across the U.S. each week. But, chief of the vaccine initiative Dr Moncef Slaoui said only five to 20 percent of treatments – made by Eli … Read more
Public health officials have looked to random antibody testing to gauge what percentage of various populations have been infected with coronavirus. But these figures are likely an underestimate, the findings of a new Centers for Disease Control and Prevention (CDC) report suggests. Among more than 150 health care workers who had tested positive for coronavirus, … Read more
FDA gives emergency approval a new test that can measure a patient’s levels of antibodies thought to ‘neutralize’ coronavirus in the hopes of discovering how much is enough to prevent reinfection The FDA has authorized one of the first tests that measure the level of coronavirus neutralizing antibodies produced by the immune system Unlike binding … Read more